New hope for patients with Life-Threatening seizures?
NCT ID NCT02052739
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 30 times
Summary
This study tested a drug called SAGE-547 in 25 people with super-refractory status epilepticus, a life-threatening condition where seizures do not stop with standard treatments. The main goal was to see if the drug is safe and tolerable when added to usual care. The study was completed, but results are not yet available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUPER-REFRACTORY STATUS EPILEPTICUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sage Investigational Site
Birmingham, Alabama, 35294, United States
-
Sage Investigational Site
Sarasota, Florida, 34239, United States
-
Sage Investigational Site
Chicago, Illinois, 60611, United States
-
Sage Investigational Site
Wichita, Kansas, 67214, United States
-
Sage Investigational Site
New Orleans, Louisiana, 70121, United States
-
Sage Investigational Site
Boston, Massachusetts, 02114, United States
-
Sage Investigational Site
Boston, Massachusetts, 02115, United States
-
Sage Investigational Site
Ann Arbor, Michigan, 48109, United States
-
Sage Investigational Site
Detroit, Michigan, 48322, United States
-
Sage Investigational Site
New York, New York, 10032, United States
-
Sage Investigational Site
Rochester, New York, 14642, United States
-
Sage Investigational Site
Durham, North Carolina, 27710, United States
-
Sage Investigational Site
Winston-Salem, North Carolina, 27157, United States
-
Sage Investigational Site
Philadelphia, Pennsylvania, 19104, United States
-
Sage Investigational Site
Nashville, Tennessee, 37232, United States
-
Sage Investigational Site
Dallas, Texas, 75251, United States
-
Sage Investigational Site
Temple, Texas, 76504, United States
Conditions
Explore the condition pages connected to this study.